These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15599805)

  • 1. Decitabine. MGI Pharma Inc/SuperGen Inc.
    Arthur C
    IDrugs; 2004 Dec; 7(12):1113-32. PubMed ID: 15599805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of DNA methylation: beyond myelodysplastic syndromes.
    Fenaux P
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S36-44. PubMed ID: 16341239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
    Cowan LA; Talwar S; Yang AS
    Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decitabine: development of a DNA methyltransferase inhibitor for hematological malignancies.
    Lyons J; Bayar E; Fine G; McCullar M; Rolens R; Rubinfeld J; Rosenfeld C
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1442-50. PubMed ID: 14763130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.
    Drugs R D; 2003; 4(3):179-84. PubMed ID: 12757405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decitabine.
    Daskalakis M; Blagitko-Dorfs N; Hackanson B
    Recent Results Cancer Res; 2010; 184():131-57. PubMed ID: 20072836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-azacytidine and decitabine monotherapies of myelodysplastic disorders.
    Kuykendall JR
    Ann Pharmacother; 2005 Oct; 39(10):1700-9. PubMed ID: 16144884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection.
    Issa JP
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S24-9. PubMed ID: 16341237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation inhibitor therapy in the treatment of myelodysplastic syndrome.
    Silverman LR; Mufti GJ
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S12-23. PubMed ID: 16341236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
    Stresemann C; Lyko F
    Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
    Lowder JN; Taverna P; Issa JP
    Epigenomics; 2015 Oct; 7(7):1083-8. PubMed ID: 26541345
    [No Abstract]   [Full Text] [Related]  

  • 12. Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.
    Drugs R D; 2003; 4(6):352-8. PubMed ID: 14584964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting DNA methylation.
    Issa JP; Kantarjian HM
    Clin Cancer Res; 2009 Jun; 15(12):3938-46. PubMed ID: 19509174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors.
    Nie J; Liu L; Li X; Han W
    Cancer Lett; 2014 Nov; 354(1):12-20. PubMed ID: 25130173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine in myelodysplastic syndromes: viewpoints.
    Garcia-Manero G; Saba HI
    Drugs; 2006; 66(7):959-60. PubMed ID: 16740015
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
    Samlowski WE; Leachman SA; Wade M; Cassidy P; Porter-Gill P; Busby L; Wheeler R; Boucher K; Fitzpatrick F; Jones DA; Karpf AR
    J Clin Oncol; 2005 Jun; 23(17):3897-905. PubMed ID: 15753459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drugs: a longstanding story.
    de Vos D
    Semin Oncol; 2005 Oct; 32(5):437-42. PubMed ID: 16210083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decitabine is an effective treatment of idiopathic myelofibrosis.
    Danilov AV; Relias V; Feeney DM; Miller KB
    Br J Haematol; 2009 Apr; 145(1):131-2. PubMed ID: 19133981
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action.
    Lübbert M
    Curr Top Microbiol Immunol; 2000; 249():135-64. PubMed ID: 10802943
    [No Abstract]   [Full Text] [Related]  

  • 20. Decitabine and its role in the treatment of hematopoietic malignancies.
    Plimack ER; Kantarjian HM; Issa JP
    Leuk Lymphoma; 2007 Aug; 48(8):1472-81. PubMed ID: 17701577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.